KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strategy (MSTR) Asset Writedowns and Impairment (2016 - 2024)

Historic Asset Writedowns and Impairment for Strategy (MSTR) over the last 15 years, with Q4 2024 value amounting to -$783.2 million.

  • Strategy's Asset Writedowns and Impairment fell 94107.36% to -$783.2 million in Q4 2024 from the same period last year, while for Sep 2025 it was -$783.2 million, marking a year-over-year decrease of 21052.48%. This contributed to the annual value of $649000.0 for FY2024, which is 5320.84% down from last year.
  • Per Strategy's latest filing, its Asset Writedowns and Impairment stood at -$783.2 million for Q4 2024, which was down 94107.36% from $412.1 million recorded in Q3 2024.
  • In the past 5 years, Strategy's Asset Writedowns and Impairment registered a high of $917.8 million during Q2 2022, and its lowest value of -$1.1 billion during Q4 2022.
  • Its 5-year average for Asset Writedowns and Impairment is $4.0 million, with a median of $33.6 million in 2023.
  • The largest annual percentage gain for Strategy's Asset Writedowns and Impairment in the last 5 years was 2334142.51% (2021), contrasted with its biggest fall of 267556.6% (2021).
  • Strategy's Asset Writedowns and Impairment (Quarter) stood at $26.5 million in 2020, then plummeted by 2675.57% to -$682.5 million in 2021, then tumbled by 59.37% to -$1.1 billion in 2022, then skyrocketed by 93.08% to -$75.2 million in 2023, then plummeted by 941.07% to -$783.2 million in 2024.
  • Its Asset Writedowns and Impairment stands at -$783.2 million for Q4 2024, versus $412.1 million for Q3 2024 and $180.1 million for Q2 2024.